Pediatrics
News from the FDA/CDC
FDA approves ninth Humira biosimilar, with interchangeability
The drug, adalimumab-afzb (Abrilada), is the second adalimumab biosimilar approved with interchangeability status. It will be available in late...
Commentary
Social media makes kids with type 1 diabetes feel less alone
I have had numerous patients – many of whom have struggled to accept their diagnosis – mention with joy and excitement that they were following an...
From the Journals
Adolescents’ acute care use for eating disorders has risen
“Eating disorders tend to fester amid silence and isolation and inactivity, and that was very much our experience during the lockdown phase of the...
News
Preparing for the viral trifecta: RSV, influenza, and COVID-19
News from the FDA/CDC
FDA approves first tocilizumab biosimilar
Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.
Guidelines
AHA updates CPR guidelines on cardiac arrest after poisoning
The update reflects treatment advances and new knowledge, including the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for...
Latest News
Study finds inflammatory bowel disease risk higher in children, adults with atopic dermatitis
AD has been associated with an increasing number of comorbidities, including IBD, but studies linking AD with IBD have had mixed results,...
From the Journals
Diagnosing pediatric forearm fractures: Radiograph or ultrasound?
“With an ultrasound-first approach, clinicians can scan the patient at time of review and may even be able to discharge them immediately (2/3 of...
Latest News
European Commission grants approval of ritlecitinib for severe alopecia areata
In June of 2023, ritlecitinib was approved by the FDA for treatment of severe alopecia areata in people ages 12 and older in the United States.
From the Journals
Dialectical behavior therapy decreased suicide attempts in bipolar teens
DBT also was associated with improved emotional regulation, compared with standard of care.
From the Journals
Surge in pediatric ADHD med errors prompts call for prevention
The most common scenario was “inadvertently taken or given medication twice.”